Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Petros Pharmaceuticals's total assets was $3.55M at Jun 30, 2026. For fiscal 2025 it was $5.16M, down 51.4% from the year before. The highest annual figure on record is $69.85M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.16M | -51.4% |
| FY2024 | Dec 31, 2024 | $10.64M | -68.5% |
| FY2023 | Dec 31, 2023 | $33.80M | +4.2% |
| FY2022 | Dec 31, 2022 | $32.42M | -51.9% |
| FY2021 | Dec 31, 2021 | $67.39M | -3.5% |
| FY2020 | Dec 31, 2020 | $69.85M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.55M | -52.1% |
| Q1 FY2026 | Mar 31, 2026 | $4.39M | -75.0% |
| Q4 FY2025 | Dec 31, 2025 | $5.16M | -51.4% |
| Q3 FY2025 | Sep 30, 2025 | $6.13M | -70.4% |
| Q2 FY2025 | Jun 30, 2025 | $7.40M | -70.6% |
| Q1 FY2025 | Mar 31, 2025 | $17.61M | -41.9% |
| Q4 FY2024 | Dec 31, 2024 | $10.64M | -68.5% |
| Q3 FY2024 | Sep 30, 2024 | $20.69M | -46.8% |
| Q2 FY2024 | Jun 30, 2024 | $25.17M | -12.4% |
| Q1 FY2024 | Mar 31, 2024 | $30.31M | -0.8% |
| Q4 FY2023 | Dec 31, 2023 | $33.80M | +4.2% |
| Q3 FY2023 | Sep 30, 2023 | $38.91M | +3.2% |
| Q2 FY2023 | Jun 30, 2023 | $28.73M | -43.7% |
| Q1 FY2023 | Mar 31, 2023 | $30.57M | -45.3% |
| Q4 FY2022 | Dec 31, 2022 | $32.42M | -51.9% |
| Q3 FY2022 | Sep 30, 2022 | $37.70M | -33.5% |
| Q2 FY2022 | Jun 30, 2022 | $51.05M | -22.8% |
| Q1 FY2022 | Mar 31, 2022 | $55.86M | -20.0% |
| Q4 FY2021 | Dec 31, 2021 | $67.39M | – |
| Q2 FY2021 | Jun 30, 2021 | $56.67M | – |
| Q1 FY2021 | Mar 31, 2021 | $66.15M | – |
| Q4 FY2020 | Dec 31, 2020 | $69.85M | – |
See a number that looks wrong?